Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast November 21, 2024 TV ads focused on health care issues — including transgender…
Originally broadcast November 14, 2024 There are 27 million Americans who have medical debt on…
Originally broadcast November 6, 2024The current life expectancy at birth is 74.8 years for males…
Originally broadcast April 9, 2024 The upcoming presidential election is stressing out 69% of American…
Originally broadcast October 17, 2024 For nearly the first decade of the National Institutes of…
Originally broadcast October 10, 2024 The countdown is on to election day with health care…